🇺🇸 FDA
Pipeline program

Tenofovir Alafenamide

GS-US-465-4439

Phase 2 small_molecule completed

Quick answer

Tenofovir Alafenamide for Chronic Hepatitis B is a Phase 2 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Vir Biotechnology
Indication
Chronic Hepatitis B
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials